2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
  • United States
  • United Kingdom
  • Ireland
  • Switzerland
Investment stages
  • Series C
  • Growth
Industries
  • Healthcare
  • Biotech
About
K2 HealthVentures is a healthcare-focused investment firm providing customized financing solutions to innovative companies. Their mission is to partner with commercial and late-stage life sciences companies to accelerate growth and create shareholder value. They operate as a strategic partner, offering deep expertise in the healthcare sector.
Min check size
$5M
Max check size
$50M
Fund size
NPS

Investment Thesis

K2 HealthVentures provides flexible, long-term, and minimally-dilutive financing solutions to innovative life sciences and healthcare companies. They focus on commercial-stage and late development-stage companies within the biopharmaceutical, medical device, and diagnostic sectors. K2HV positions itself as a collaborative, long-term strategic partner, leveraging deep domain and capital markets expertise to help management teams accelerate growth and innovation.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

The founding partners, Parag Shah and Anup Arora, each bring over 20 years of experience in healthcare finance, with previous leadership roles at Hercules Capital's Life Sciences practice. Their backgrounds include experience at major corporations like Bristol-Myers Squibb and GE Capital. The team is further strengthened by medical and scientific expertise, such as Dr. Shaan Ghandi, a former physician at Massachusetts General Hospital and venture investor at Longwood Fund, blending deep financial, operational, and clinical knowledge.

K2 HealthVentures Contacts Information

Primary contact

Secondary contact

Team

Parag Shah - Founding Managing Partner & CEO

Anup Arora - Founding Managing Partner & CIO

Bob Altevogt - Managing Director

Head of Credit

John R. H. H. Plews - Managing Director

Head of Life Sciences

Shaan C. Ghandi

M.D.

D.Phil. - Managing Director

Head of Biopharma

Gerassimos G. “Makis” Spyredakis - Managing Director

Head of Medical Devices

Nimesh Shah - Managing Director

Head of Therapeutics

Portfolio

Hims & Hers

Novavax

Pacira

Radius Health

Sarepta

Veracyte

Curis

Inari Medical

Insmed

Castle Biosciences

Axsome Therapeutics

Bridgebio

Dermira

Viela Bio

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp